A detailed history of Israel Englander (Millennium Management LLC) transactions in Cor Medix Inc. stock. As of the latest transaction made, Millennium Management LLC holds 90,238 shares of CRMD stock, worth $898,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,238
Previous 446,752 79.8%
Holding current value
$898,770
Previous $1.93 Million 62.31%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.64 - $8.23 $1.3 Million - $2.93 Million
-356,514 Reduced 79.8%
90,238 $729,000
Q2 2024

Aug 14, 2024

BUY
$4.08 - $6.39 $1.78 Million - $2.78 Million
435,644 Added 3921.89%
446,752 $1.93 Million
Q1 2024

May 15, 2024

SELL
$2.94 - $4.24 $814,809 - $1.18 Million
-277,146 Reduced 96.15%
11,108 $47,000
Q4 2023

Feb 14, 2024

SELL
$3.0 - $4.01 $689,235 - $921,277
-229,745 Reduced 44.35%
288,254 $1.08 Million
Q2 2023

Aug 14, 2023

BUY
$3.94 - $5.8 $807,806 - $1.19 Million
205,027 Added 65.51%
517,999 $2.05 Million
Q1 2023

May 15, 2023

SELL
$3.22 - $4.61 $867,677 - $1.24 Million
-269,465 Reduced 46.27%
312,972 $1.3 Million
Q4 2022

Feb 14, 2023

BUY
$2.81 - $4.45 $37,035 - $58,651
13,180 Added 2.32%
582,437 $2.46 Million
Q3 2022

Nov 14, 2022

SELL
$2.82 - $7.52 $329,923 - $879,794
-116,994 Reduced 17.05%
569,257 $1.61 Million
Q2 2022

Aug 15, 2022

BUY
$2.73 - $5.61 $1.81 Million - $3.73 Million
664,473 Added 3051.12%
686,251 $2.76 Million
Q1 2022

May 16, 2022

BUY
$3.83 - $6.24 $83,409 - $135,894
21,778 New
21,778 $119,000
Q4 2020

Feb 16, 2021

SELL
$5.0 - $9.15 $535,230 - $979,470
-107,046 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$3.96 - $6.15 $423,902 - $658,332
107,046 New
107,046 $645,000
Q4 2019

Feb 14, 2020

SELL
$4.96 - $7.75 $125,582 - $196,222
-25,319 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$6.38 - $9.69 $218,948 - $332,541
-34,318 Reduced 57.54%
25,319 $161,000
Q2 2019

Aug 15, 2019

BUY
$5.93 - $10.57 $262,224 - $467,405
44,220 Added 286.83%
59,637 $535,000
Q2 2019

Aug 14, 2019

SELL
$5.93 - $10.57 $1.28 Million - $2.28 Million
-215,506 Reduced 93.32%
15,417 $33,000
Q1 2019

May 14, 2019

BUY
$6.95 - $13.25 $1.6 Million - $3.06 Million
230,923 New
230,923 $2.18 Million

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $410M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.